

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.87476828 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.52702151 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.48265277 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.48265277 |
| 5 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.17539793 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 5.01924174 |
| 7 | positive thymic T cell selection (GO:0045059) | 4.93121119 |
| 8 | regulation of gamma-delta T cell activation (GO:0046643) | 4.72257440 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.63600609 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.63600609 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 4.63600609 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 4.63600609 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 4.63600609 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.63600609 |
| 15 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.62875746 |
| 16 | negative regulation of interleukin-12 production (GO:0032695) | 4.57567376 |
| 17 | negative T cell selection (GO:0043383) | 4.48159493 |
| 18 | negative thymic T cell selection (GO:0045060) | 4.42293955 |
| 19 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.40188724 |
| 20 | response to peptidoglycan (GO:0032494) | 4.30449849 |
| 21 | negative regulation of cell killing (GO:0031342) | 4.25388190 |
| 22 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.25388190 |
| 23 | response to interleukin-15 (GO:0070672) | 4.21299930 |
| 24 | B cell receptor signaling pathway (GO:0050853) | 4.20671462 |
| 25 | detection of molecule of bacterial origin (GO:0032490) | 4.18541183 |
| 26 | thymic T cell selection (GO:0045061) | 4.16037907 |
| 27 | interferon-gamma production (GO:0032609) | 4.11421550 |
| 28 | positive T cell selection (GO:0043368) | 4.09317369 |
| 29 | T cell selection (GO:0045058) | 3.90731196 |
| 30 | microglial cell activation (GO:0001774) | 3.90017359 |
| 31 | regulation of B cell differentiation (GO:0045577) | 3.87421722 |
| 32 | cellular response to interleukin-15 (GO:0071350) | 3.85508124 |
| 33 | neutrophil activation (GO:0042119) | 3.81845969 |
| 34 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.80461869 |
| 35 | macrophage activation (GO:0042116) | 3.79522305 |
| 36 | detection of other organism (GO:0098543) | 3.76299369 |
| 37 | regulation of T cell tolerance induction (GO:0002664) | 3.61202041 |
| 38 | granulocyte activation (GO:0036230) | 3.60545657 |
| 39 | positive regulation of B cell differentiation (GO:0045579) | 3.59419055 |
| 40 | detection of external biotic stimulus (GO:0098581) | 3.58672846 |
| 41 | tolerance induction (GO:0002507) | 3.53779723 |
| 42 | leukocyte aggregation (GO:0070486) | 3.51604603 |
| 43 | myeloid cell activation involved in immune response (GO:0002275) | 3.50711725 |
| 44 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.47383873 |
| 45 | regulation of mast cell activation (GO:0033003) | 3.46535241 |
| 46 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.44802351 |
| 47 | immunoglobulin mediated immune response (GO:0016064) | 3.39268141 |
| 48 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.34087330 |
| 49 | indolalkylamine catabolic process (GO:0046218) | 3.32427089 |
| 50 | tryptophan catabolic process (GO:0006569) | 3.32427089 |
| 51 | indole-containing compound catabolic process (GO:0042436) | 3.32427089 |
| 52 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.29542346 |
| 53 | response to host immune response (GO:0052572) | 3.29107584 |
| 54 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.29107584 |
| 55 | detection of bacterium (GO:0016045) | 3.29033614 |
| 56 | type I interferon signaling pathway (GO:0060337) | 3.29005089 |
| 57 | cellular response to type I interferon (GO:0071357) | 3.29005089 |
| 58 | positive regulation of mast cell activation (GO:0033005) | 3.28036047 |
| 59 | response to type I interferon (GO:0034340) | 3.27449447 |
| 60 | leukocyte degranulation (GO:0043299) | 3.26914130 |
| 61 | T cell migration (GO:0072678) | 3.25836054 |
| 62 | T cell costimulation (GO:0031295) | 3.25505646 |
| 63 | aromatic amino acid family catabolic process (GO:0009074) | 3.23858281 |
| 64 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.22802104 |
| 65 | negative regulation of T cell mediated immunity (GO:0002710) | 3.22081526 |
| 66 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.20900188 |
| 67 | tryptophan metabolic process (GO:0006568) | 3.19344921 |
| 68 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.17248057 |
| 69 | L-phenylalanine catabolic process (GO:0006559) | 3.17248057 |
| 70 | lymphocyte costimulation (GO:0031294) | 3.16708382 |
| 71 | regulation of mast cell degranulation (GO:0043304) | 3.15926926 |
| 72 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.15012478 |
| 73 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.13981901 |
| 74 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.12045856 |
| 75 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.11995553 |
| 76 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.10870442 |
| 77 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.08523843 |
| 78 | detection of biotic stimulus (GO:0009595) | 3.08216884 |
| 79 | kynurenine metabolic process (GO:0070189) | 3.08020869 |
| 80 | T cell receptor signaling pathway (GO:0050852) | 3.07466986 |
| 81 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.06799693 |
| 82 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.04288520 |
| 83 | L-phenylalanine metabolic process (GO:0006558) | 3.03925174 |
| 84 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.03925174 |
| 85 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.02634353 |
| 86 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.02461011 |
| 87 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.01154334 |
| 88 | positive regulation of humoral immune response (GO:0002922) | 2.98451878 |
| 89 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.96380865 |
| 90 | response to host (GO:0075136) | 2.96380865 |
| 91 | response to host defenses (GO:0052200) | 2.96380865 |
| 92 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.96203019 |
| 93 | urea cycle (GO:0000050) | 2.94176151 |
| 94 | urea metabolic process (GO:0019627) | 2.94176151 |
| 95 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.93887340 |
| 96 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.93692835 |
| 97 | regulation of response to interferon-gamma (GO:0060330) | 2.93379217 |
| 98 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.93218264 |
| 99 | natural killer cell activation involved in immune response (GO:0002323) | 2.92992771 |
| 100 | neutrophil mediated immunity (GO:0002446) | 2.91546620 |
| 101 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.90394793 |
| 102 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.90279632 |
| 103 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.89878208 |
| 104 | positive regulation of mast cell degranulation (GO:0043306) | 2.89878208 |
| 105 | respiratory burst (GO:0045730) | 2.88802538 |
| 106 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.87845065 |
| 107 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.86654087 |
| 108 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.86526034 |
| 109 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.85606133 |
| 110 | negative regulation of interleukin-6 production (GO:0032715) | 2.82557016 |
| 111 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.81751657 |
| 112 | positive regulation of interleukin-2 production (GO:0032743) | 2.81529417 |
| 113 | myeloid leukocyte activation (GO:0002274) | 2.80923599 |
| 114 | superoxide anion generation (GO:0042554) | 2.80791871 |
| 115 | mature B cell differentiation (GO:0002335) | 2.80202675 |
| 116 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.79904509 |
| 117 | cellular extravasation (GO:0045123) | 2.78809854 |
| 118 | cellular response to zinc ion (GO:0071294) | 2.77367475 |
| 119 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.76069838 |
| 120 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.75677848 |
| 121 | regulation of antigen processing and presentation (GO:0002577) | 2.75118479 |
| 122 | T-helper 1 type immune response (GO:0042088) | 2.74807090 |
| 123 | regulation of superoxide anion generation (GO:0032928) | 2.73173520 |
| 124 | defense response to protozoan (GO:0042832) | 2.73124722 |
| 125 | germinal center formation (GO:0002467) | 2.71728793 |
| 126 | complement activation, classical pathway (GO:0006958) | 2.71196465 |
| 127 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.71157560 |
| 128 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.70217908 |
| 129 | negative regulation of interleukin-17 production (GO:0032700) | 2.69635699 |
| 130 | negative regulation of fibrinolysis (GO:0051918) | 2.69099811 |
| 131 | complement activation, alternative pathway (GO:0006957) | 2.68296773 |
| 132 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.67622290 |
| 133 | positive regulation of histone deacetylation (GO:0031065) | 2.67348551 |
| 134 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.66297682 |
| 135 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.65328516 |
| 136 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.65056398 |
| 137 | regulation of leukocyte degranulation (GO:0043300) | 2.65040278 |
| 138 | positive regulation of tolerance induction (GO:0002645) | 2.64838614 |
| 139 | dendritic cell migration (GO:0036336) | 2.64627771 |
| 140 | negative regulation of interleukin-1 production (GO:0032692) | 2.63109632 |
| 141 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.62825249 |
| 142 | phospholipid efflux (GO:0033700) | 2.62330846 |
| 143 | positive regulation of interferon-alpha production (GO:0032727) | 2.61902674 |
| 144 | neutrophil chemotaxis (GO:0030593) | 2.61597772 |
| 145 | leukocyte cell-cell adhesion (GO:0007159) | 2.61541460 |
| 146 | response to protozoan (GO:0001562) | 2.61010390 |
| 147 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.60992670 |
| 148 | response to muramyl dipeptide (GO:0032495) | 2.60818575 |
| 149 | regulation of triglyceride catabolic process (GO:0010896) | 2.60159449 |
| 150 | regulation of B cell proliferation (GO:0030888) | 2.59973651 |
| 151 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.59850804 |
| 152 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.59850804 |
| 153 | alpha-linolenic acid metabolic process (GO:0036109) | 2.59381562 |
| 154 | nitrogen cycle metabolic process (GO:0071941) | 2.58428533 |
| 155 | regulation of protein activation cascade (GO:2000257) | 2.56645644 |
| 156 | regulation of extracellular matrix disassembly (GO:0010715) | 2.55329997 |
| 157 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.54696558 |
| 158 | positive regulation of immunoglobulin production (GO:0002639) | 2.54416555 |
| 159 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.54026342 |
| 160 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.54026342 |
| 161 | macrophage activation involved in immune response (GO:0002281) | 2.52686392 |
| 162 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.50931221 |
| 163 | activated T cell proliferation (GO:0050798) | 2.50787269 |
| 164 | regulation of tolerance induction (GO:0002643) | 2.50085141 |
| 165 | bile acid biosynthetic process (GO:0006699) | 2.49880488 |
| 166 | positive regulation of isotype switching (GO:0045830) | 2.49735503 |
| 167 | negative regulation of cholesterol transport (GO:0032375) | 2.49580119 |
| 168 | negative regulation of sterol transport (GO:0032372) | 2.49580119 |
| 169 | B cell proliferation (GO:0042100) | 2.49409789 |
| 170 | regulation of humoral immune response (GO:0002920) | 2.49378836 |
| 171 | regulation of cholesterol homeostasis (GO:2000188) | 2.49051456 |
| 172 | regulation of interferon-alpha production (GO:0032647) | 2.48631208 |
| 173 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.48488462 |
| 174 | complement activation (GO:0006956) | 2.47899205 |
| 175 | lymphocyte homeostasis (GO:0002260) | 2.47774714 |
| 176 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.47480589 |
| 177 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.46479759 |
| 178 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.44285943 |
| 179 | regulation of fibrinolysis (GO:0051917) | 2.44141154 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.32042584 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.04145069 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.44648994 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.05835835 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.29010864 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.25853276 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 3.14903830 |
| 8 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.14722337 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.11297747 |
| 10 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.98362702 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.82428600 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.80837131 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.74814680 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.74174402 |
| 15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.72515696 |
| 16 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.65868810 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.61190720 |
| 18 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.58642782 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.57145751 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.52242502 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 2.50170136 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.45476566 |
| 23 | MYB_26560356_Chip-Seq_TH1_Human | 2.39663703 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 2.38294812 |
| 25 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.31123110 |
| 26 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.20407213 |
| 27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.14587825 |
| 28 | UTX_26944678_Chip-Seq_JUKART_Human | 2.14293623 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.11623450 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.09140660 |
| 31 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.03649866 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.93970092 |
| 33 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.87430782 |
| 34 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.85429544 |
| 35 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.83736092 |
| 36 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.81006188 |
| 37 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.80658897 |
| 38 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.80295906 |
| 39 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77776512 |
| 40 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.77421307 |
| 41 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.76030704 |
| 42 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.68131872 |
| 43 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.66195892 |
| 44 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.66160806 |
| 45 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.63523080 |
| 46 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.62394857 |
| 47 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59699923 |
| 48 | GATA1_22025678_ChIP-Seq_K562_Human | 1.59546795 |
| 49 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.53380993 |
| 50 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.53231391 |
| 51 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.49594478 |
| 52 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.49377969 |
| 53 | MAF_26560356_Chip-Seq_TH2_Human | 1.47611635 |
| 54 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.42396522 |
| 55 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.42317436 |
| 56 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40857365 |
| 57 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39670425 |
| 58 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.36118869 |
| 59 | SPI1_23127762_ChIP-Seq_K562_Human | 1.35839952 |
| 60 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.35784255 |
| 61 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.35254168 |
| 62 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.33722002 |
| 63 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.33645735 |
| 64 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.28281305 |
| 65 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.27878771 |
| 66 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25805757 |
| 67 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.25012167 |
| 68 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23982699 |
| 69 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23052482 |
| 70 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.16694021 |
| 71 | GATA3_26560356_Chip-Seq_TH2_Human | 1.13644584 |
| 72 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.11370507 |
| 73 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10856709 |
| 74 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10602764 |
| 75 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.10081087 |
| 76 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08651137 |
| 77 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07403574 |
| 78 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.03216317 |
| 79 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01234382 |
| 80 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.99441053 |
| 81 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98952744 |
| 82 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98187587 |
| 83 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95957244 |
| 84 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.95840006 |
| 85 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95687910 |
| 86 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.93778104 |
| 87 | CJUN_26792858_Chip-Seq_BT549_Human | 0.93540237 |
| 88 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91171073 |
| 89 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.90691722 |
| 90 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90465740 |
| 91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.90382425 |
| 92 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89581673 |
| 93 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.88807804 |
| 94 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.88730143 |
| 95 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.88378924 |
| 96 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87916657 |
| 97 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.86690357 |
| 98 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.86642558 |
| 99 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.86525478 |
| 100 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.86175211 |
| 101 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85885131 |
| 102 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.85809573 |
| 103 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.85721243 |
| 104 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.85721243 |
| 105 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85403446 |
| 106 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.85361069 |
| 107 | TP53_16413492_ChIP-PET_HCT116_Human | 0.84774582 |
| 108 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.84590929 |
| 109 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84190741 |
| 110 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83608331 |
| 111 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83282819 |
| 112 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83235135 |
| 113 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.82106669 |
| 114 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.82105070 |
| 115 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81960822 |
| 116 | GATA1_19941826_ChIP-Seq_K562_Human | 0.81078609 |
| 117 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80086474 |
| 118 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.79964504 |
| 119 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.79677569 |
| 120 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79417845 |
| 121 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.79400570 |
| 122 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.78766135 |
| 123 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.76392711 |
| 124 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.76346567 |
| 125 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.74273882 |
| 126 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.73452418 |
| 127 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.70180273 |
| 128 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.69956930 |
| 129 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.69221116 |
| 130 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.68676914 |
| 131 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.67472579 |
| 132 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.66963870 |
| 133 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.66673946 |
| 134 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.66532570 |
| 135 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.65932068 |
| 136 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.65443332 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 3.51212964 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.38443154 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.28808074 |
| 4 | MP0001800_abnormal_humoral_immune | 3.08379058 |
| 5 | MP0001790_abnormal_immune_system | 2.94010466 |
| 6 | MP0005387_immune_system_phenotype | 2.94010466 |
| 7 | MP0003763_abnormal_thymus_physiology | 2.85924739 |
| 8 | MP0005671_abnormal_response_to | 2.82600634 |
| 9 | MP0005365_abnormal_bile_salt | 2.79342274 |
| 10 | MP0005085_abnormal_gallbladder_physiolo | 2.78425205 |
| 11 | MP0000685_abnormal_immune_system | 2.62613606 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.40756895 |
| 13 | MP0003303_peritoneal_inflammation | 2.36080671 |
| 14 | MP0003252_abnormal_bile_duct | 2.35456266 |
| 15 | MP0002723_abnormal_immune_serum | 2.32146381 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.26728991 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.26323123 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.20891553 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.19833806 |
| 20 | MP0001819_abnormal_immune_cell | 2.16809829 |
| 21 | MP0003436_decreased_susceptibility_to | 2.13245385 |
| 22 | MP0009840_abnormal_foam_cell | 2.11050679 |
| 23 | MP0002398_abnormal_bone_marrow | 2.01161071 |
| 24 | MP0005167_abnormal_blood-brain_barrier | 1.93883568 |
| 25 | MP0000569_abnormal_digit_pigmentation | 1.92628914 |
| 26 | MP0009785_altered_susceptibility_to | 1.91147965 |
| 27 | MP0001873_stomach_inflammation | 1.90385804 |
| 28 | MP0000716_abnormal_immune_system | 1.89988855 |
| 29 | MP0005025_abnormal_response_to | 1.88990549 |
| 30 | MP0008875_abnormal_xenobiotic_pharmacok | 1.88732236 |
| 31 | MP0000343_altered_response_to | 1.85207649 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.82158487 |
| 33 | MP0000689_abnormal_spleen_morphology | 1.79108183 |
| 34 | MP0002419_abnormal_innate_immunity | 1.77948845 |
| 35 | MP0006082_CNS_inflammation | 1.77543162 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.76589765 |
| 37 | MP0005464_abnormal_platelet_physiology | 1.71905687 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.70506216 |
| 39 | MP0002405_respiratory_system_inflammati | 1.67604749 |
| 40 | MP0000609_abnormal_liver_physiology | 1.65850847 |
| 41 | MP0002396_abnormal_hematopoietic_system | 1.65466092 |
| 42 | MP0002722_abnormal_immune_system | 1.65076927 |
| 43 | MP0004947_skin_inflammation | 1.63755871 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.63692658 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.63061716 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.61917595 |
| 47 | MP0004883_abnormal_blood_vessel | 1.61529643 |
| 48 | MP0005164_abnormal_response_to | 1.58542025 |
| 49 | MP0003724_increased_susceptibility_to | 1.58459339 |
| 50 | MP0003075_altered_response_to | 1.58401528 |
| 51 | MP0002148_abnormal_hypersensitivity_rea | 1.55986331 |
| 52 | MP0001853_heart_inflammation | 1.54285720 |
| 53 | MP0002429_abnormal_blood_cell | 1.53966996 |
| 54 | MP0006054_spinal_hemorrhage | 1.48422125 |
| 55 | MP0010329_abnormal_lipoprotein_level | 1.46246667 |
| 56 | MP0008260_abnormal_autophagy | 1.41243606 |
| 57 | MP0000703_abnormal_thymus_morphology | 1.40011685 |
| 58 | MP0002998_abnormal_bone_remodeling | 1.39000424 |
| 59 | MP0008469_abnormal_protein_level | 1.35464529 |
| 60 | MP0000604_amyloidosis | 1.30625208 |
| 61 | MP0001666_abnormal_nutrient_absorption | 1.28284023 |
| 62 | MP0008004_abnormal_stomach_pH | 1.27986757 |
| 63 | MP0002006_tumorigenesis | 1.26666201 |
| 64 | MP0002933_joint_inflammation | 1.23492617 |
| 65 | MP0004510_myositis | 1.20592617 |
| 66 | MP0009764_decreased_sensitivity_to | 1.17693079 |
| 67 | MP0004808_abnormal_hematopoietic_stem | 1.17154033 |
| 68 | MP0003866_abnormal_defecation | 1.15960306 |
| 69 | MP0003868_abnormal_feces_composition | 1.14848734 |
| 70 | MP0005451_abnormal_body_composition | 1.12339913 |
| 71 | MP0002277_abnormal_respiratory_mucosa | 1.09858379 |
| 72 | MP0005166_decreased_susceptibility_to | 1.08756682 |
| 73 | MP0003690_abnormal_glial_cell | 1.02477379 |
| 74 | MP0002928_abnormal_bile_duct | 1.02451056 |
| 75 | MP0000858_altered_metastatic_potential | 0.98167833 |
| 76 | MP0000465_gastrointestinal_hemorrhage | 0.98103017 |
| 77 | MP0009763_increased_sensitivity_to | 0.98102235 |
| 78 | MP0001533_abnormal_skeleton_physiology | 0.95802258 |
| 79 | MP0005670_abnormal_white_adipose | 0.95296111 |
| 80 | MP0009643_abnormal_urine_homeostasis | 0.95237062 |
| 81 | MP0005310_abnormal_salivary_gland | 0.94359168 |
| 82 | MP0005390_skeleton_phenotype | 0.94271546 |
| 83 | MP0002136_abnormal_kidney_physiology | 0.94236452 |
| 84 | MP0009278_abnormal_bone_marrow | 0.91650443 |
| 85 | MP0004185_abnormal_adipocyte_glucose | 0.90578963 |
| 86 | MP0005083_abnormal_biliary_tract | 0.89768841 |
| 87 | MP0000598_abnormal_liver_morphology | 0.89324865 |
| 88 | MP0008961_abnormal_basal_metabolism | 0.88982570 |
| 89 | MP0005023_abnormal_wound_healing | 0.87982332 |
| 90 | MP0003011_delayed_dark_adaptation | 0.87273955 |
| 91 | MP0003195_calcinosis | 0.87151258 |
| 92 | MP0002118_abnormal_lipid_homeostasis | 0.87093825 |
| 93 | MP0005332_abnormal_amino_acid | 0.86424801 |
| 94 | MP0005397_hematopoietic_system_phenotyp | 0.85376588 |
| 95 | MP0001545_abnormal_hematopoietic_system | 0.85376588 |
| 96 | MP0005319_abnormal_enzyme/_coenzyme | 0.83249997 |
| 97 | MP0003045_fibrosis | 0.82837390 |
| 98 | MP0003950_abnormal_plasma_membrane | 0.82412257 |
| 99 | MP0010368_abnormal_lymphatic_system | 0.82157132 |
| 100 | MP0000015_abnormal_ear_pigmentation | 0.81985911 |
| 101 | MP0002332_abnormal_exercise_endurance | 0.81203447 |
| 102 | MP0001663_abnormal_digestive_system | 0.80159337 |
| 103 | MP0001851_eye_inflammation | 0.79872963 |
| 104 | MP0005165_increased_susceptibility_to | 0.79784759 |
| 105 | MP0003795_abnormal_bone_structure | 0.79400763 |
| 106 | MP0003183_abnormal_peptide_metabolism | 0.78470404 |
| 107 | MP0000249_abnormal_blood_vessel | 0.78360088 |
| 108 | MP0003453_abnormal_keratinocyte_physiol | 0.74970305 |
| 109 | MP0002877_abnormal_melanocyte_morpholog | 0.74830678 |
| 110 | MP0003656_abnormal_erythrocyte_physiolo | 0.73511052 |
| 111 | MP0004019_abnormal_vitamin_homeostasis | 0.73070397 |
| 112 | MP0003448_altered_tumor_morphology | 0.71743151 |
| 113 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.71243938 |
| 114 | MP0002019_abnormal_tumor_incidence | 0.70759392 |
| 115 | MP0005174_abnormal_tail_pigmentation | 0.70275099 |
| 116 | MP0003806_abnormal_nucleotide_metabolis | 0.69914853 |
| 117 | MP0005058_abnormal_lysosome_morphology | 0.68814221 |
| 118 | MP0002132_abnormal_respiratory_system | 0.68041732 |
| 119 | MP0003828_pulmonary_edema | 0.67564686 |
| 120 | MP0003566_abnormal_cell_adhesion | 0.67495717 |
| 121 | MP0001958_emphysema | 0.67339492 |
| 122 | MP0005595_abnormal_vascular_smooth | 0.65030490 |
| 123 | MP0005666_abnormal_adipose_tissue | 0.64355983 |
| 124 | MP0004484_altered_response_of | 0.64050366 |
| 125 | MP0003279_aneurysm | 0.63869531 |
| 126 | MP0002168_other_aberrant_phenotype | 0.63569181 |
| 127 | MP0001879_abnormal_lymphatic_vessel | 0.63320810 |
| 128 | MP0009642_abnormal_blood_homeostasis | 0.63082678 |
| 129 | MP0001542_abnormal_bone_strength | 0.61934283 |
| 130 | MP0009765_abnormal_xenobiotic_induced | 0.61781382 |
| 131 | MP0004130_abnormal_muscle_cell | 0.59286943 |
| 132 | MP0000371_diluted_coat_color | 0.59026574 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Retrobulbar optic neuritis (HP:0100654) | 5.10855719 |
| 2 | Optic neuritis (HP:0100653) | 5.10855719 |
| 3 | Abnormality of macrophages (HP:0004311) | 4.95118971 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 4.55863668 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.55863668 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.55863668 |
| 7 | Agammaglobulinemia (HP:0004432) | 4.41716442 |
| 8 | Recurrent bronchitis (HP:0002837) | 4.23375576 |
| 9 | T lymphocytopenia (HP:0005403) | 4.07863972 |
| 10 | Abnormality of T cell number (HP:0011839) | 3.91650404 |
| 11 | Colitis (HP:0002583) | 3.85032143 |
| 12 | Recurrent viral infections (HP:0004429) | 3.81973301 |
| 13 | IgM deficiency (HP:0002850) | 3.75698977 |
| 14 | Recurrent sinusitis (HP:0011108) | 3.69510501 |
| 15 | Keratoconjunctivitis sicca (HP:0001097) | 3.68658512 |
| 16 | Inflammation of the large intestine (HP:0002037) | 3.62940023 |
| 17 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.57793689 |
| 18 | Pustule (HP:0200039) | 3.53986287 |
| 19 | Keratoconjunctivitis (HP:0001096) | 3.52063826 |
| 20 | Deep venous thrombosis (HP:0002625) | 3.51944459 |
| 21 | Recurrent fungal infections (HP:0002841) | 3.43633737 |
| 22 | Gastrointestinal inflammation (HP:0004386) | 3.41367068 |
| 23 | Vacuolated lymphocytes (HP:0001922) | 3.37904491 |
| 24 | Hemoptysis (HP:0002105) | 3.33147850 |
| 25 | Abnormality of T cells (HP:0002843) | 3.30810035 |
| 26 | Myocardial infarction (HP:0001658) | 3.26930601 |
| 27 | Autoimmune thrombocytopenia (HP:0001973) | 3.26271223 |
| 28 | Verrucae (HP:0200043) | 3.23124228 |
| 29 | Papilloma (HP:0012740) | 3.23124228 |
| 30 | Chronic obstructive pulmonary disease (HP:0006510) | 3.20979514 |
| 31 | Obstructive lung disease (HP:0006536) | 3.20979514 |
| 32 | Panhypogammaglobulinemia (HP:0003139) | 3.16934333 |
| 33 | Increased cerebral lipofuscin (HP:0011813) | 3.15902357 |
| 34 | Complement deficiency (HP:0004431) | 3.13854930 |
| 35 | Abnormality of the fingertips (HP:0001211) | 3.12842119 |
| 36 | Meningitis (HP:0001287) | 3.07790783 |
| 37 | Spontaneous hematomas (HP:0007420) | 3.07600395 |
| 38 | Gastrointestinal stroma tumor (HP:0100723) | 3.07503910 |
| 39 | Lymphopenia (HP:0001888) | 3.06666330 |
| 40 | Nasal polyposis (HP:0100582) | 3.06327757 |
| 41 | Recurrent cutaneous fungal infections (HP:0011370) | 3.04551088 |
| 42 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.04551088 |
| 43 | Chronic otitis media (HP:0000389) | 3.00672605 |
| 44 | Urticaria (HP:0001025) | 2.99726913 |
| 45 | Intrahepatic cholestasis (HP:0001406) | 2.98946889 |
| 46 | Eczematoid dermatitis (HP:0000976) | 2.96885249 |
| 47 | Chronic diarrhea (HP:0002028) | 2.96470640 |
| 48 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.95514025 |
| 49 | Petechiae (HP:0000967) | 2.95334093 |
| 50 | Gingivitis (HP:0000230) | 2.94832526 |
| 51 | Cellulitis (HP:0100658) | 2.94226115 |
| 52 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.89789483 |
| 53 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.89126930 |
| 54 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.87375081 |
| 55 | Vasculitis (HP:0002633) | 2.86887652 |
| 56 | Prolonged partial thromboplastin time (HP:0003645) | 2.78606250 |
| 57 | Myositis (HP:0100614) | 2.76335052 |
| 58 | Dysostosis multiplex (HP:0000943) | 2.75114010 |
| 59 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.72368594 |
| 60 | Recurrent bacterial skin infections (HP:0005406) | 2.70577590 |
| 61 | Joint hemorrhage (HP:0005261) | 2.70190162 |
| 62 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.69970033 |
| 63 | Abnormality of the nasal mucosa (HP:0000433) | 2.69770382 |
| 64 | Xanthomatosis (HP:0000991) | 2.67299879 |
| 65 | Recurrent abscess formation (HP:0002722) | 2.67061164 |
| 66 | Abnormality of T cell physiology (HP:0011840) | 2.66131238 |
| 67 | Loss of speech (HP:0002371) | 2.64628062 |
| 68 | Encephalitis (HP:0002383) | 2.64088292 |
| 69 | Recurrent skin infections (HP:0001581) | 2.61688648 |
| 70 | Mitral stenosis (HP:0001718) | 2.59538609 |
| 71 | Episodic fever (HP:0001954) | 2.58480741 |
| 72 | Combined immunodeficiency (HP:0005387) | 2.57076120 |
| 73 | Peritonitis (HP:0002586) | 2.54389970 |
| 74 | IgG deficiency (HP:0004315) | 2.54052811 |
| 75 | Recurrent otitis media (HP:0000403) | 2.50637596 |
| 76 | Anorexia (HP:0002039) | 2.47952534 |
| 77 | Gingival bleeding (HP:0000225) | 2.47712147 |
| 78 | Emphysema (HP:0002097) | 2.47454244 |
| 79 | Bronchitis (HP:0012387) | 2.47269789 |
| 80 | Abnormality of the common coagulation pathway (HP:0010990) | 2.47101681 |
| 81 | Abnormal platelet volume (HP:0011876) | 2.44795418 |
| 82 | Abnormal platelet function (HP:0011869) | 2.44096493 |
| 83 | Impaired platelet aggregation (HP:0003540) | 2.44096493 |
| 84 | Abnormality of iron homeostasis (HP:0011031) | 2.43802831 |
| 85 | Gangrene (HP:0100758) | 2.43260448 |
| 86 | IgA deficiency (HP:0002720) | 2.41446914 |
| 87 | Thyroiditis (HP:0100646) | 2.41047453 |
| 88 | Systemic lupus erythematosus (HP:0002725) | 2.40022289 |
| 89 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.38338728 |
| 90 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.38338728 |
| 91 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.38338728 |
| 92 | Abnormality of the pericardium (HP:0001697) | 2.35839201 |
| 93 | Hypobetalipoproteinemia (HP:0003563) | 2.35372034 |
| 94 | Epistaxis (HP:0000421) | 2.33530703 |
| 95 | Polyneuropathy (HP:0001271) | 2.33369565 |
| 96 | Joint swelling (HP:0001386) | 2.32866074 |
| 97 | Severe combined immunodeficiency (HP:0004430) | 2.32586964 |
| 98 | Increased serum ferritin (HP:0003281) | 2.32503813 |
| 99 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.30947823 |
| 100 | Hyperlipoproteinemia (HP:0010980) | 2.30454685 |
| 101 | Amyloidosis (HP:0011034) | 2.29911565 |
| 102 | Chest pain (HP:0100749) | 2.29461232 |
| 103 | Stomatitis (HP:0010280) | 2.29336811 |
| 104 | Chronic sinusitis (HP:0011109) | 2.27848111 |
| 105 | Abnormality of B cell number (HP:0010975) | 2.27188091 |
| 106 | B lymphocytopenia (HP:0010976) | 2.27188091 |
| 107 | Glomerulonephritis (HP:0000099) | 2.26816240 |
| 108 | Increased IgM level (HP:0003496) | 2.22388799 |
| 109 | Pulmonary embolism (HP:0002204) | 2.21566761 |
| 110 | Purpura (HP:0000979) | 2.21118181 |
| 111 | Abnormality of complement system (HP:0005339) | 2.18290596 |
| 112 | Vertigo (HP:0002321) | 2.17698252 |
| 113 | Eosinophilia (HP:0001880) | 2.16808426 |
| 114 | Keratitis (HP:0000491) | 2.16524880 |
| 115 | Mediastinal lymphadenopathy (HP:0100721) | 2.15429963 |
| 116 | Cheilitis (HP:0100825) | 2.14590461 |
| 117 | Hematochezia (HP:0002573) | 2.14517284 |
| 118 | Abnormality of the pleura (HP:0002103) | 2.14176329 |
| 119 | Increased mean platelet volume (HP:0011877) | 2.13617857 |
| 120 | Mucopolysacchariduria (HP:0008155) | 2.13462416 |
| 121 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.13462416 |
| 122 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.12519772 |
| 123 | Pulmonary infiltrates (HP:0002113) | 2.12344578 |
| 124 | Prolonged bleeding time (HP:0003010) | 2.10929882 |
| 125 | Osteomyelitis (HP:0002754) | 2.09692843 |
| 126 | Hepatitis (HP:0012115) | 2.06999929 |
| 127 | Arterial thrombosis (HP:0004420) | 2.05831963 |
| 128 | Gastrointestinal infarctions (HP:0005244) | 2.05229217 |
| 129 | Aortic aneurysm (HP:0004942) | 2.01439031 |
| 130 | Abnormality of eosinophils (HP:0001879) | 2.01415038 |
| 131 | Leukocytosis (HP:0001974) | 2.00255200 |
| 132 | Orchitis (HP:0100796) | 1.99890929 |
| 133 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.94165376 |
| 134 | Periodontitis (HP:0000704) | 1.93143448 |
| 135 | Fat malabsorption (HP:0002630) | 1.92892040 |
| 136 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.90172502 |
| 137 | Microcytic anemia (HP:0001935) | 1.89802948 |
| 138 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.87197491 |
| 139 | Polycythemia (HP:0001901) | 1.86999379 |
| 140 | Thrombocytosis (HP:0001894) | 1.85941260 |
| 141 | Glomerulopathy (HP:0100820) | 1.85816300 |
| 142 | Recurrent pneumonia (HP:0006532) | 1.85265138 |
| 143 | Increased IgE level (HP:0003212) | 1.85062032 |
| 144 | Acne (HP:0001061) | 1.84359297 |
| 145 | Hypergammaglobulinemia (HP:0010702) | 1.84072868 |
| 146 | Menorrhagia (HP:0000132) | 1.83688616 |
| 147 | Hepatosplenomegaly (HP:0001433) | 1.82035441 |
| 148 | Granulocytopenia (HP:0001913) | 1.82022114 |
| 149 | Hypochromic microcytic anemia (HP:0004840) | 1.80027038 |
| 150 | Conjunctival telangiectasia (HP:0000524) | 1.78224682 |
| 151 | Abnormality of the endocardium (HP:0004306) | 1.77353380 |
| 152 | Hypochromic anemia (HP:0001931) | 1.77230645 |
| 153 | Autoimmune hemolytic anemia (HP:0001890) | 1.77077427 |
| 154 | Increased CSF protein (HP:0002922) | 1.76162319 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.64823851 |
| 2 | TXK | 3.10391064 |
| 3 | ERN1 | 2.95432124 |
| 4 | FGFR4 | 2.63147586 |
| 5 | STK10 | 2.62929736 |
| 6 | TYK2 | 2.49850306 |
| 7 | GRK6 | 2.41897762 |
| 8 | MAP3K10 | 2.24475852 |
| 9 | JAK1 | 2.23874862 |
| 10 | ZAP70 | 2.15814213 |
| 11 | JAK3 | 2.10642309 |
| 12 | TAOK3 | 2.08998528 |
| 13 | TIE1 | 2.07047417 |
| 14 | TGFBR2 | 2.07009286 |
| 15 | ITK | 2.06195198 |
| 16 | IRAK1 | 1.98936593 |
| 17 | BLK | 1.92785629 |
| 18 | MAP3K14 | 1.89871775 |
| 19 | IRAK3 | 1.78542056 |
| 20 | ADRBK2 | 1.77330091 |
| 21 | CSK | 1.70994794 |
| 22 | MARK3 | 1.68734407 |
| 23 | IKBKE | 1.65166139 |
| 24 | CSF1R | 1.62890491 |
| 25 | ACVR1B | 1.59174569 |
| 26 | NLK | 1.58529376 |
| 27 | GRK7 | 1.58258708 |
| 28 | SIK1 | 1.55455844 |
| 29 | TBK1 | 1.54354348 |
| 30 | FGFR3 | 1.51839175 |
| 31 | CDK12 | 1.51385826 |
| 32 | BTK | 1.51052730 |
| 33 | MAP3K3 | 1.49662470 |
| 34 | TRIB3 | 1.44603952 |
| 35 | EEF2K | 1.44344698 |
| 36 | SYK | 1.43749307 |
| 37 | NEK9 | 1.42413933 |
| 38 | FGR | 1.40743289 |
| 39 | MAP3K13 | 1.40072447 |
| 40 | MATK | 1.38692197 |
| 41 | IRAK4 | 1.31744531 |
| 42 | TEC | 1.31197572 |
| 43 | MAP3K11 | 1.27480105 |
| 44 | CAMKK2 | 1.26239923 |
| 45 | RPS6KA4 | 1.22565026 |
| 46 | PKN2 | 1.19119481 |
| 47 | KIT | 1.19078124 |
| 48 | LCK | 1.18738532 |
| 49 | FLT3 | 1.16961050 |
| 50 | HCK | 1.16921602 |
| 51 | IKBKB | 1.16095636 |
| 52 | PIK3CG | 1.13375409 |
| 53 | SIK2 | 1.09404715 |
| 54 | PIM1 | 1.09070943 |
| 55 | PTK2B | 1.08203155 |
| 56 | LRRK2 | 1.06909636 |
| 57 | EPHB1 | 1.05899438 |
| 58 | KDR | 1.00462647 |
| 59 | JAK2 | 0.98459517 |
| 60 | PRKCQ | 0.97479610 |
| 61 | MAP3K6 | 0.95631729 |
| 62 | BMPR2 | 0.94416251 |
| 63 | LYN | 0.93850086 |
| 64 | MAP2K6 | 0.93830697 |
| 65 | PTK6 | 0.92962308 |
| 66 | FRK | 0.90756772 |
| 67 | CHUK | 0.88137305 |
| 68 | PRKCH | 0.87996152 |
| 69 | PRKD2 | 0.86600408 |
| 70 | DAPK2 | 0.83688778 |
| 71 | MAPK7 | 0.83216567 |
| 72 | MST4 | 0.80228211 |
| 73 | MAP3K7 | 0.79382813 |
| 74 | MAPK12 | 0.78287265 |
| 75 | CDK4 | 0.75248788 |
| 76 | ADRBK1 | 0.74307231 |
| 77 | CLK1 | 0.73917944 |
| 78 | MAPK11 | 0.72771055 |
| 79 | FER | 0.72536665 |
| 80 | CAMK1D | 0.72383731 |
| 81 | MELK | 0.72318562 |
| 82 | MAP3K1 | 0.71172915 |
| 83 | MAP2K3 | 0.70383163 |
| 84 | PDK1 | 0.69818460 |
| 85 | CDK9 | 0.68636668 |
| 86 | PDK2 | 0.67469137 |
| 87 | TGFBR1 | 0.66842688 |
| 88 | SIK3 | 0.66827317 |
| 89 | MAP2K4 | 0.65394776 |
| 90 | TLK1 | 0.63400110 |
| 91 | CDK6 | 0.63079382 |
| 92 | PINK1 | 0.61782787 |
| 93 | SGK3 | 0.61521855 |
| 94 | MAP3K2 | 0.60980754 |
| 95 | NEK2 | 0.59524736 |
| 96 | EPHA3 | 0.58860857 |
| 97 | CAMK1G | 0.56670991 |
| 98 | RIPK4 | 0.56584044 |
| 99 | MAP3K5 | 0.54929668 |
| 100 | PRKAA2 | 0.53494034 |
| 101 | HIPK2 | 0.53288120 |
| 102 | STK3 | 0.48941708 |
| 103 | FES | 0.47812300 |
| 104 | YES1 | 0.46955386 |
| 105 | NUAK1 | 0.46378105 |
| 106 | MAPK15 | 0.45880791 |
| 107 | TRPM7 | 0.45209619 |
| 108 | TTN | 0.44553435 |
| 109 | STK4 | 0.42919689 |
| 110 | ABL1 | 0.42367497 |
| 111 | MOS | 0.40107430 |
| 112 | PDGFRB | 0.38804806 |
| 113 | INSRR | 0.38435175 |
| 114 | OXSR1 | 0.38080516 |
| 115 | IRAK2 | 0.37705145 |
| 116 | BRSK2 | 0.37084618 |
| 117 | STK11 | 0.37030231 |
| 118 | MAPKAPK2 | 0.36871192 |
| 119 | LATS1 | 0.36284625 |
| 120 | PRKCD | 0.35263796 |
| 121 | DDR2 | 0.35209952 |
| 122 | PRKD1 | 0.34983494 |
| 123 | PRKG2 | 0.34058824 |
| 124 | INSR | 0.33965141 |
| 125 | MTOR | 0.33802388 |
| 126 | PDPK1 | 0.33762219 |
| 127 | TAOK1 | 0.33194042 |
| 128 | GRK5 | 0.32506387 |
| 129 | TNK2 | 0.32399495 |
| 130 | CDC42BPA | 0.32026123 |
| 131 | BMPR1B | 0.31812300 |
| 132 | FYN | 0.31338136 |
| 133 | STK24 | 0.30630895 |
| 134 | MAPK4 | 0.29999994 |
| 135 | IGF1R | 0.29508864 |
| 136 | BRD4 | 0.29106689 |
| 137 | KSR2 | 0.27246352 |
| 138 | SGK2 | 0.26899886 |
| 139 | GRK1 | 0.25951922 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.08501059 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.87705958 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.81922400 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.73761112 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.35159044 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.27343205 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.25185788 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.11548654 |
| 9 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.02837233 |
| 10 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.01855081 |
| 11 | Asthma_Homo sapiens_hsa05310 | 1.94539576 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.93633094 |
| 13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.93259760 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.84226244 |
| 15 | Lysosome_Homo sapiens_hsa04142 | 1.82358041 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.80436552 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.80143024 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.75681189 |
| 19 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.67688534 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.67658236 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.66972575 |
| 22 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.66655791 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.66067026 |
| 24 | Phagosome_Homo sapiens_hsa04145 | 1.64497201 |
| 25 | Lysine degradation_Homo sapiens_hsa00310 | 1.54441838 |
| 26 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.53470769 |
| 27 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.48493323 |
| 28 | Leishmaniasis_Homo sapiens_hsa05140 | 1.46905312 |
| 29 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.39967540 |
| 30 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.39626061 |
| 31 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.36733630 |
| 32 | ABC transporters_Homo sapiens_hsa02010 | 1.35274489 |
| 33 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.21346901 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.20548862 |
| 35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.14183672 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.08370947 |
| 37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.07870816 |
| 38 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.07464239 |
| 39 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.06367372 |
| 40 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.06179921 |
| 41 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.06013965 |
| 42 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.05690162 |
| 43 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.02192674 |
| 44 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.00971282 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.00848647 |
| 46 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.99998150 |
| 47 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.99206049 |
| 48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.99143091 |
| 49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.98142381 |
| 50 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.97741619 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.97464965 |
| 52 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.97057720 |
| 53 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.96843381 |
| 54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.96410513 |
| 55 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.96142419 |
| 56 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.94840209 |
| 57 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.94699173 |
| 58 | Influenza A_Homo sapiens_hsa05164 | 0.93861236 |
| 59 | Retinol metabolism_Homo sapiens_hsa00830 | 0.93513976 |
| 60 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.88976641 |
| 61 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.88645412 |
| 62 | Histidine metabolism_Homo sapiens_hsa00340 | 0.88000521 |
| 63 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.87303217 |
| 64 | Hepatitis B_Homo sapiens_hsa05161 | 0.86749379 |
| 65 | Viral myocarditis_Homo sapiens_hsa05416 | 0.86357249 |
| 66 | Insulin resistance_Homo sapiens_hsa04931 | 0.85111416 |
| 67 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.84489317 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.82915955 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.82899370 |
| 70 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.81239471 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.81052016 |
| 72 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80936104 |
| 73 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.80056718 |
| 74 | Peroxisome_Homo sapiens_hsa04146 | 0.79987480 |
| 75 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.77688564 |
| 76 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.76405322 |
| 77 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.74521189 |
| 78 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.72672849 |
| 79 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.72450836 |
| 80 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.71805260 |
| 81 | Tuberculosis_Homo sapiens_hsa05152 | 0.71327817 |
| 82 | Apoptosis_Homo sapiens_hsa04210 | 0.70721386 |
| 83 | Hepatitis C_Homo sapiens_hsa05160 | 0.70563146 |
| 84 | Allograft rejection_Homo sapiens_hsa05330 | 0.69281692 |
| 85 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.69034591 |
| 86 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69010823 |
| 87 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.68329750 |
| 88 | Amoebiasis_Homo sapiens_hsa05146 | 0.67894728 |
| 89 | Other glycan degradation_Homo sapiens_hsa00511 | 0.65332872 |
| 90 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.65190292 |
| 91 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.64258500 |
| 92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62987848 |
| 93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.62702349 |
| 94 | Bile secretion_Homo sapiens_hsa04976 | 0.60245010 |
| 95 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.60212647 |
| 96 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.59841014 |
| 97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59619662 |
| 98 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57863369 |
| 99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.57296262 |
| 100 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.56477124 |
| 101 | Mineral absorption_Homo sapiens_hsa04978 | 0.53911152 |
| 102 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53100423 |
| 103 | Pertussis_Homo sapiens_hsa05133 | 0.52791897 |
| 104 | * NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.52403430 |
| 105 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51959712 |
| 106 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.50878001 |
| 107 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.50713994 |
| 108 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.50086307 |
| 109 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49048524 |
| 110 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.47430209 |
| 111 | Malaria_Homo sapiens_hsa05144 | 0.46395138 |
| 112 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.45515349 |
| 113 | Legionellosis_Homo sapiens_hsa05134 | 0.45307314 |
| 114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44494869 |
| 115 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.43741247 |
| 116 | Endocytosis_Homo sapiens_hsa04144 | 0.43588093 |
| 117 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43209171 |
| 118 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43099736 |
| 119 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.43072315 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43024087 |
| 121 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42633209 |
| 122 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42585186 |
| 123 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.41105887 |
| 124 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.40547997 |
| 125 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.40384208 |
| 126 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.39726802 |
| 127 | Shigellosis_Homo sapiens_hsa05131 | 0.39220519 |
| 128 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37959957 |
| 129 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34992319 |
| 130 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.34713350 |
| 131 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.33861396 |
| 132 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.31301147 |
| 133 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.30108269 |
| 134 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.29632604 |
| 135 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.29313858 |
| 136 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.28740252 |
| 137 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.27865320 |
| 138 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.23602296 |

